QuidelOrtho (QDEL) Cash from Investing Activities (2021 - 2026)

QuidelOrtho (QDEL) reported Cash from Investing Activities of -$34.0 million for Q1 2026, up 39.5% on a YoY basis from -$24.4 million in Q1 2025, and up 31.45% sequentially from -$49.6 million in Q4 2025.

QuidelOrtho (QDEL) Cash from Investing Activities (2021 - 2026) Analysis & Trends

QuidelOrtho (QDEL) has 6 years of Cash from Investing Activities data on file, last reported at -$34.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Investing Activities rose 39.5% year-over-year to -$34.0 million; the trailing twelve-month figure through Mar 2026 stood at -$170.5 million (up 8.28% YoY), and the FY2025 full-year result was -$192.7 million, down 28.55% from the prior year.
  • Cash from Investing Activities rose to -$34.0 million in Q1 2026, from -$49.6 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$20.2 million in Q1 2024 to a low of -$1.4 billion in Q1 2023.
  • A 5-year average of -$134.0 million and a median of -$42.3 million in 2023 frame the typical range for Cash from Investing Activities.
  • Peak annual rise in Cash from Investing Activities reached 96.12% in 2023, while the deepest fall reached 178.95% in 2023.
  • Tracing QDEL's Cash from Investing Activities over 5 years: stood at -$24.7 million in 2022, then slumped by 123.08% to -$55.1 million in 2023, then jumped by 31.22% to -$37.9 million in 2024, then sank by 30.87% to -$49.6 million in 2025, then soared by 31.45% to -$34.0 million in 2026.
  • Business Quant data shows QDEL's Cash from Investing Activities at -$34.0 million in Q1 2026, -$49.6 million in Q4 2025, and -$53.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -20.32 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -185.00 Mn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -92.80 Mn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -298.50 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -2.50 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn -475.32 Mn
10 QuidelOrtho 1.15 Bn 1.01 Bn - -34.00 Mn

Historic Data

Download Data
DateValue
Mar 29, 2026 -34.00 Mn
Mar 29, 2026 -34.00 Mn
Dec 28, 2025 -49.60 Mn
Dec 28, 2025 -49.60 Mn
Sep 28, 2025 -53.90 Mn
Sep 28, 2025 -53.90 Mn
Jun 29, 2025 -33.00 Mn
Jun 29, 2025 -33.00 Mn
Mar 30, 2025 -56.20 Mn
Mar 30, 2025 -56.20 Mn
Dec 29, 2024 -37.90 Mn
Dec 29, 2024 -37.90 Mn
Sep 29, 2024 -56.50 Mn
Sep 29, 2024 -56.50 Mn
Jun 30, 2024 -35.30 Mn
Jun 30, 2024 -35.30 Mn
Mar 31, 2024 -20.20 Mn
Mar 31, 2024 -20.20 Mn
Dec 31, 2023 -55.10 Mn
Dec 31, 2023 -55.10 Mn